Lymphatic spread from left-sided intrahepatic cholangiocarcinoma: reconsiderations based on the lymphatic drainage from the liver

Abstract

Intrahepatic cholangiocarcinoma (ICC) is known to have a high frequency of lymph node metastasis. Lymph node dissection (LND) is recommended for accurate staging, but the survival benefit of LND remains unclear. Knowledge of the pathways and direction of lymphatic drainage to the regional lymph nodes is essential when considering LND to improve patient survival. The liver has three lymphatic drainage pathways: portal, sublobular, and subcapsular. Of these, the portal lymphatic pathway, which lies along with the portal tracts, is the primary pathway. The efferent portal lymphatic vessels from the left-sided liver, which continue from the portal lymphatic pathway of the liver, communicate with the lymphatic vessels and lymph nodes along the hepatic artery at the hepatoduodenal ligament. In addition, lymphatic flow may also present along the left embryonic (aberrant) hepatic artery in the lesser omentum, based on our experience. This pathway is the previously reported pathway from the left-sided ICC to the lesser curvature of the stomach. However, through this pathway, ICC cells reach lymph nodes along the root of the left gastric artery but not the perigastric lymph nodes along the lesser curvature because of the opposite direction of lymph flow. Although further analyses using a large number of cases are needed to confirm these observations, these two pathways, along the hepatic artery at the hepatoduodenal ligament and the left embryonic (aberrant) hepatic artery in the lesser omentum should be considered when performing LND in the case of ICC in the left-sided liver.

Keywords

Surgery / intrahepatic cholangiocarcinoma / left-sided liver / lymphatic spread / lymph node dissection

References

[1] Amin MB. American joint committee on cancer. AJCC Cancer Staging Manual. 8th ed. Chicago: Springer; 2016. pp. 295-302.

[2] Brierley JD,Wittekind C. Union for international cancer control (UICC). TNM Classification of Malignant Tumours. 8th ed. Oxford: Wiley Blackwell; 2016. pp. 83-4.

[3] Jeong J,Iwakiri Y.Hepatic lymphatic vascular system in health and disease.J Hepatol2022;77:206-18.

[4] Ohtani O.Lymph circulation in the liver.Anat Rec2008;291:643-52

[5] Morine Y.The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics.J Gastroenterol2015;50:913-27

[6] Cho HS.Nomenclature and lymphatic drainage patterns of abdominal lymph nodes.J Korean Soc Radiol2022;83:1240-58 PMCID:PMC9748447

[7] Tsuji T,Kanemitsu K,Tanabe D.Lymphatic spreading pattern of intrahepatic cholangiocarcinoma.Surgery2001;129:401-7

[8] Okami J,Sakon M.Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe.J Gastrointest Surg2003;7:850-6

[9] Koops A,Broering DC,Krupski-Berdien G.Anatomic variations of the hepatic arteries in 604 selective celiac and superior mesenteric angiographies.Surg Radiol Anat2004;26:239-44

[10] Wang BG.Accessory extrahepatic arteries: blood supply of a human liver by three arteries. A case report with brief literature review.Ann Anat2009;191:477-84.

[11] Dolenšek J.Triple arterial blood supply to the liver and double cystic arteries.Folia Morphol2017;76:523-6

[12] Yi SQ,Akita K.Anatomical study of the pancreas in the house musk shrew (Suncus murinus), with special reference to the blood supply and innervation.Anat Rec A Discov Mol Cell Evol Biol2003;273:630-5

[13] Zhang XF,Weiss M.Lymph node examination and patterns of nodal metastasis among patients with left- versus right-sided intrahepatic cholangiocarcinoma after major curative-intent resection.Ann Surg Oncol2023;30:1424-33

[14] Umeda Y,Kojima T.Impact of lymph node dissection on clinical outcomes of intrahepatic cholangiocarcinoma: inverse probability of treatment weighting with survival analysis.J Hepatobiliary Pancreat Sci2022;29:217-29

[15] Primrose JN,Palmer DH.BILCAP study groupCapecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.Lancet Oncol2019;20:663-73

[16] Nakachi K,Konishi M.Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG)Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.Lancet2023;401:195-203

[17] Kim SH,Choi GH,Kim KS.Extent of lymph node dissection for accurate staging in intrahepatic cholangiocarcinoma.J Gastrointest Surg2022;26:70-6

[18] Moazzam Z,Endo Y,Pawlik TM.Predictors, patterns, and impact of adequate lymphadenectomy in intrahepatic cholangiocarcinoma.Ann Surg Oncol2023;30:1966-77

[19] Zhu J,Li H.Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: a population-based study.Cancer Med2023;12:8184-98 PMCID:PMC10134328

[20] Igami T,Yokoyama Y,Takahashi Y.Staging of peripheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications.World J Surg2011;35:2501-9